Recent Updates
Recently added Catalysts
PHG Positive Sentiment

Philips et Imricor lancent une solution de laboratoire d'IRM interventionnelle cardiaque, renforçant ainsi leur collaboration de longue date

Friday, August 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Royal Philips and Imricor Medical Systems have launched a new interventional MRI lab solution for Philips' 1.5 T MRI system. This product marks a significant advancement in their long-standing collaboration, aimed at enhancing cardiac procedures. The new solution is expected to improve the efficiency and effectiveness of interventional MRI applications.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of a new interventional MRI lab solution
  • Strengthening collaboration between Philips and Imricor
  • Innovative technology for cardiac procedures

Full Press Release Details

AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE : PHG, AEX : PHIA), leader mondial des technologies du secteur de la santé, et Imricor Medical Systems (ASX : IMR), pionnier et leader mondial du développement de produits compatibles avec l’IRM dans les procédures d’IRM interventionnelle, ont annoncé aujourd’hui une nouvelle solution de laboratoire d’IRM interventionnelle pour l'IRM à 1,5 T de Philips. La première configuration disponible sur le marché* associe la plateforme IRM à 1,5 T de Philip

Frequently Asked Questions

What is the new product launched by Philips and Imricor?

The new product is an interventional MRI lab solution for Philips' 1.5 T MRI system.

How does this launch impact Philips and Imricor's collaboration?

The launch strengthens the long-standing collaboration between Philips and Imricor.

What is the significance of the new MRI lab solution?

It aims to enhance the efficiency and effectiveness of cardiac interventional procedures.

ShareAdd on Google
Tags: PHG Viatris Investor Conferences Healthcare Philips Imricor interventional MRI cardiac procedures medical technology
Last updated: Aug 28, 2026